Trial intelligence / Profile preview

ZODIAC: Ziprasidone vs Olanzapine Cardiovascular Safety

NCT00418171Phase 4Completed

Sponsor
Pfizer
Start
Feb 2002
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of ziprasidone in schizophrenia, sponsored by Pfizer. Started Feb 2002; status: completed.

02

Drugs

ziprasidone
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT00418171.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00418171.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call